Delivery Order SPE2DX22D0010-SPE2D825FFE80
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Metadate CD Caps 10mg, a medication commonly used to treat attention deficit hyperactivity disorder. This firm fixed-price delivery order carries a ceiling value of $2,541.81 and is scheduled for completion by August 27, 2025. The contract was awarded on a competitive basis with no set-aside designation, and performance will be executed from...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Metadate CD Caps 30mg, a methylphenidate-based medication used to treat attention deficit hyperactivity disorder. This firm fixed price delivery order, valued at $8,397.85 with a completion deadline of August 26, 2025, represents a competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on April 23, 2025, for the supply of Metadate CD Caps 20mg, a central nervous system stimulant medication used to treat attention deficit hyperactivity disorder. This non-set-aside, competitively awarded contract is structured as a firm fixed price delivery order with a ceiling value of $5,438.69 and an ultimate completion date of April 24, 2025. The performance location is...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Metadate CD Caps 20mg, a methylphenidate-based medication used to treat attention deficit hyperactivity disorder. This competitively awarded, firm fixed-price delivery order has a ceiling value of $2,006.19 and an ultimate completion date of August 13, 2025. The work will be performed at AmerisourceBergen's corporate office location in...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for Metadate CD Caps 30mg, a methylphenidate-based attention deficit hyperactivity disorder medication. This firm fixed-price delivery order, valued at $6,920.67, is set to be completed by September 18, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a competitive procurement with no set-aside...
- On July 18, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $4,295.31 to AmerisourceBergen Drug Corp for Metadate CD Caps 30mg. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation and an ultimate completion date of July 21, 2025. The contract is being performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Metadate CD Caps 20mg, a methylphenidate-based medication used for attention deficit hyperactivity disorder treatment. This non-set-aside, competitively awarded contract is valued at $5,541.86 with a firm fixed price structure and an ultimate completion date of August 27, 2025. The order was executed on August 26, 2025, with performance taking place at...
- The U.S. Department of Defense's Medical Supply Chain awarded a $1,516.09 delivery order to AmerisourceBergen Drug Corp for Metadate CD Caps 20mg, a controlled-release methylphenidate medication used to treat attention deficit hyperactivity disorder. This competitively awarded, firm fixed-price delivery order was issued on June 27, 2025, with an ultimate completion date of June 30, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with the Defense...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Metadate CD 30mg tablets, valued at $9,277.04. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 1, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's broader pharmaceutical supply...
- The U.S. Defense Department's Medical Supply Chain awarded a $3,784.33 delivery order to AmerisourceBergen Drug Corp for Metadate CD Caps 30mg, a methylphenidate-based medication used to treat attention deficit hyperactivity disorder. This competitive award, issued on May 30, 2025, represents a firm fixed-price delivery order with a completion deadline of June 2, 2025. The contract carries no small business set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania,...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D825FFE80Delivery Order
The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Metadate CD Caps 20mg, a medication used to treat attention deficit hyperactivity disorder. This competitively awarded, firm fixed-price delivery order has a ceiling value of $7,322.65 with an ultimate completion date of April 25, 2025. The contract utilizes no set-aside designation and will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor serving federal military and healthcare systems, AmerisourceBergen regularly fulfills medical supply needs through the DLA, supplying a comprehensive portfolio of pharmaceutical products, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support Defense Health Agency and other government healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.3k | 4/24/25 |